FindTrial
Sign In

A pilot randomized study: Radiofrequency ablation of hepatocellular carcinoma sized >3 and = 5 cm: Is ablative margin of more than 1 cm justified?

A pilot randomized study: Radiofrequency ablation of hepatocellular carcinoma sized >3 and = 5 cm: Is ablative margin of more than 1 cm justified?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006089
Enrollment
Unknown
Registered
2015-03-13
Start date
2015-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Control:No treatment
Experimental:Repeated radiofrequncy ablation

Sponsors

Beijing Chao-yang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The tumor 3.1 to 5.0 cm at its greatest diameter on preoperative investigations; 2. a single primary HCC; 3. Child-Pugh class A or B; 4. patients who must be voluntary to the trail and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Extrahepatic metastasis; 2. unfeasible for RF ablation because of concurrent severe comorbidities; 3. the patients refuse the experiment.

Design outcomes

Primary

MeasureTime frame
technique success rate;safety (complications related to ablation);local recurrence rate;local tumor progression;Overall survival;—

Secondary

MeasureTime frame
hospital costs;Quality of life;—

Countries

China

Contacts

Public ContactSun Wenbing
cyhswb@qq.com+86 010-51718382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026